Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone for Serologically Active, Clinically Stable SLE
NCT00000421Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Sep 1997
- Primary completion
- Aug 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisone in systemic lupus erythematosus (SLE), sponsored by NYU Langone Health. Started Sep 1997; status: completed.
02
Drugs
prednisone
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00000421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000421.